NI200900113A - FORMA CRISTALINA DEL HEMIHIDRATO DE 1-(Beta-D-GLUCOPIRANOSIL)-4-METIL-3-[5-(4-FLUOROFENIL)-2-TIENILMETIL] BENCENO. - Google Patents
FORMA CRISTALINA DEL HEMIHIDRATO DE 1-(Beta-D-GLUCOPIRANOSIL)-4-METIL-3-[5-(4-FLUOROFENIL)-2-TIENILMETIL] BENCENO.Info
- Publication number
- NI200900113A NI200900113A NI200900113A NI200900113A NI200900113A NI 200900113 A NI200900113 A NI 200900113A NI 200900113 A NI200900113 A NI 200900113A NI 200900113 A NI200900113 A NI 200900113A NI 200900113 A NI200900113 A NI 200900113A
- Authority
- NI
- Nicaragua
- Prior art keywords
- fluorophenyl
- beta
- methyl
- crystalline form
- thenylmethyl
- Prior art date
Links
- VHOFTEAWFCUTOS-TUGBYPPCSA-N canagliflozin hydrate Chemical compound O.CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1.CC1=CC=C([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C=C1CC(S1)=CC=C1C1=CC=C(F)C=C1 VHOFTEAWFCUTOS-TUGBYPPCSA-N 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 238000002329 infrared spectrum Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Una forma cristalina novedosa del hemihidrato de 1-(Beta-D-glucopiranosil)-4-metil-3-[5-(4-fluorofenil)-2-tienilmetil]benceno, que tiene características favorables, se caracteriza por su patrón de difracción de rayos X de polvo y/o por su espectro infrarrojo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86842606P | 2006-12-04 | 2006-12-04 | |
| JP2006327019 | 2006-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI200900113A true NI200900113A (es) | 2010-11-29 |
Family
ID=50486662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI200900113A NI200900113A (es) | 2006-12-04 | 2009-06-04 | FORMA CRISTALINA DEL HEMIHIDRATO DE 1-(Beta-D-GLUCOPIRANOSIL)-4-METIL-3-[5-(4-FLUOROFENIL)-2-TIENILMETIL] BENCENO. |
Country Status (3)
| Country | Link |
|---|---|
| HR (1) | HRP20140254T4 (es) |
| NI (1) | NI200900113A (es) |
| UA (1) | UA93135C2 (es) |
-
2007
- 2007-12-03 HR HRP20140254TT patent/HRP20140254T4/hr unknown
- 2007-12-03 UA UAA200906994A patent/UA93135C2/uk unknown
-
2009
- 2009-06-04 NI NI200900113A patent/NI200900113A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20140254T1 (en) | 2014-04-25 |
| HRP20140254T4 (hr) | 2021-10-29 |
| UA93135C2 (uk) | 2011-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR118450A2 (es) | FORMA CRISTALINA DEL HEMIHIDRATO DE 1-(b-D-GLUCOPIRANOSIL)-4-METIL-3-[5-(4-FLUOROFENIL)-2-TIENILMETIL]BENCENO | |
| CU23774A3 (es) | Inhibición de arni de expresión de alfa-enac | |
| MX2010007840A (es) | Formas cristalinas del dimetoxi-docetaxel y sus procedimientos de preparacion. | |
| ATE545436T1 (de) | Verwendung von thiolierten polysacchariden zum gewebeaufbau | |
| CL2008002397A1 (es) | Compuestos derivados de imidazoles biciclicos fusionados; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar neoplasia benigna o maligna. | |
| BRPI0711889B8 (pt) | método para produção de sinvastatina, composição de matéria, método para fabricação de huvastatina, método para fabricação de sinvastatina, e método para fabricação de uma composição de matéria de sinvastatina ou huvastatina | |
| CL2011003009A1 (es) | Proceso de preparacion de compuestos derivados de 4-fenil-3,5-(tio)piranodionas; compuesto intermediario; y preparacion de dicho intermediario. | |
| EA200802111A1 (ru) | Имплантаты для лечения состояний, ассоциируемых с допамином | |
| DK2451797T3 (da) | Fremgangsmåde til krystallisation for 1-(b-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-fluorphenyl)-2- thienylmethyl]benzen | |
| NI200900113A (es) | FORMA CRISTALINA DEL HEMIHIDRATO DE 1-(Beta-D-GLUCOPIRANOSIL)-4-METIL-3-[5-(4-FLUOROFENIL)-2-TIENILMETIL] BENCENO. | |
| ATE526338T1 (de) | Alkyl- und/oder alkenylether von alkyl- und/oder alkenyl(poly)glycosiden und ihre verwendung | |
| CY1114969T1 (el) | ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΗΜΙΕΝΥΔΡΟΥ 1- (β-D-ΓΛΥΚΟΠΥΡΑΝΟΖΥΛΟ) -4 -ΜΕΘΥΛΟ- 3- [5- (4-ΦΘΟΡΟΦΑΙΝΥΛΟ)-2- ΘΕΙΕΝΥΛΟΜΕΘΥΛΟ]ΒΕΝΖΟΛΙΟΥ | |
| HN2009001135A (es) | Forma cristalinas del hemihidrato de 1-(b-d-glucopiranosil)- 4-metil,3-{5-(4-fluorofenil)-2-tienilmetil} benceno | |
| CL2007002359A1 (es) | Compuestos derivados de arilpiperazina; composicion farmaceutica; y uso para tratar la depresion, ansiedad o una combinacion de ambas. | |
| JO3523B1 (ar) | صورة متبلرة من نصف هيدرات 1(b-d- جلوكو بيرانوسيل)-4-ميثيل-3-[ 5-(4-قلورو فينيل) -2-ثنيينيل ميثيل]بترين | |
| HN2009003408A (es) | Inhibicion de arni de expresion de alfa-enac | |
| DOP2005000223A (es) | Nonadepsipeptidos acilados ii |